Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

DOI Web Site Web Site 被引用文献1件

収録刊行物

  • The Lancet

    The Lancet 401 (10373), 269-280, 2023-01

    Elsevier BV

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ